Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells

MLA

Masaki Tokunaga, et al. “Fluvastatin Attenuates IGF-1-Induced ERK1/2 Activation and Cell Proliferation by Mevalonic Acid Depletion in Human Mesangial Cells.” Life Sciences, vol. 84, May 2009, pp. 725–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7da9ee38bef1440fb8edaf87883aee26&authtype=sso&custid=ns315887.

APA

Masaki Tokunaga, Masahiro Okazaki, Mika Matsumoto, Yumi Furuno, Ryota Serino, Masaaki Takeuchi, Tatsuya Shibata, Yutaka Otsuji, Haruhiko Abe, Tetsu Miyamoto, Narutoshi Kabashima, Masahito Tamura, & Mieko Miyazaki. (2009). Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells. Life Sciences, 84, 725–731.

Chicago

Masaki Tokunaga, Masahiro Okazaki, Mika Matsumoto, Yumi Furuno, Ryota Serino, Masaaki Takeuchi, Tatsuya Shibata, et al. 2009. “Fluvastatin Attenuates IGF-1-Induced ERK1/2 Activation and Cell Proliferation by Mevalonic Acid Depletion in Human Mesangial Cells.” Life Sciences 84 (May): 725–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7da9ee38bef1440fb8edaf87883aee26&authtype=sso&custid=ns315887.